Resveratrol kills infectious human fungi (yeast)

July 01, 2005

Resveratrol displayed potent antifungal activity against human pathogenic fungi (disease causing yeast). Resveratrol's ability to kill Candida albicans, the yeast that causes monilial infections in humans was confirmed under electron microscopy. These results suggest that Resveratrol could be employed as a therapeutic agent to treat fungal infections in humans. The study is published in the May 2005 issue of the journal Archives of Pharmaceutical Research.

Bromelain may have a strong ability to improve colitis

Bromelain is a mixture of protein digesting enzymes derived from the pineapple stem. Orally administered Bromelain was reported to induce clinical remission and endoscopic remission of ulcerative colitis in two patients whose disease was refractory to multi-agent conventional medical therapy (multiple combinations of drugs were not working on these patients). In this study, mice who had a genetic potential for developing colitis were treated with bromelain daily, beginning at five weeks of age. Fewer mice on Bromelain developed colitis and it was less severe if it did develop. In mice with established colitis, Bromelain decreased the severity of the colitis and the amount of tissue damage. The Bromelain was very safe even at very high doses. The research was performed at the Department of Pathology, Duke University Medical Center and is published in the June 2005 issue of the journal Clinical Immunology.